Prodrugs Part I Flashcards

1
Q

Role of Metabolism in Drug Design

A

Understanding drug metabolism and the chemical aspects of metabolic transformations lead to the introduction of the concept of prodrugs, active metabolites, soft and hard drugs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is a prodrug?

A

A prodrug is a medication that is administered as an inactive (or less than fully active chemical derivative)

Subsequently, it is converted to an active pharmacological agent in the body, often through normal metabolic processes.

A prodrug serves as a type of precursor to the intended drug.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Objectives of Prodrugs Design

A

Improve: Solubility / Stability / Absorption & Distribution / Site-selective delivery

Decrease toxicity, side effects and first pass effect.

Solve chemical formulation problems.

Slow and prolong drug action.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the characteristics of a prodrug?

A
  1. The prodrug must be readily transported to the site of action.
  2. The prodrug must be selectively cleaved to the active drug utilizing special enzymatic profile of the site. (This reduces adverse effects of teh intended drug, especially important in treatments like chemotherapy)
  3. Once the prodrug is selectively generated at the site of action, the tissue must retain the active drug without further degradation.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Classification of Prodrugs

A
  1. Carrier-linked Prodrug (Bipartate & Tripartate)

2. Bioprecursors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Carrier-linked prodrugs

A

An active drug linked to a removable carrier (usually hydrolyzable group such as ester, amide, etc…) designated as the promoiety.

The promoiety alters the physical properties of the drug to increase water or fat solubility or provide site-directed delivery.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Characteristics of an ideal drug carrier.

A
  1. Protect the drug until it reaches the site of action.
  2. Localize the drug at the site of action.
  3. Allow for release of drug.
  4. Minimize host toxicity.
  5. Biodegradable, inert, and non-immunogenic.
  6. Easily prepared and inexpensive.
  7. Stable in the dosage form.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Functional groups that are amenable to prodrug design.

A
  1. For enhanced oral absorption: Amides
  2. For Enzymatically more stable drug (than the corresponding esters): Carbamate
  3. To enhance lipophilicity & membrane permeability, of water soluble drugs: Esters
  4. To enhance the membrane permeability and absorption of a parent drug: oximes.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Types of carrier linked pro-drugs

A
  1. Bipartate prodrug (one carrier + one drug)
  2. Tripartate prodrug (one carrier connected to a drug through a linker)
  3. Mutual drug (two synergistic drugs attached to each other)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Carrier-linked Bipartate prodrugs

A

It is one carrier attached to one drug through a covalent bond. Through enzymatic activation, the carrier releases the active drug and leaves. (Promoiety)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Advantages of carrier-linked bipartate prodrugs

A
  1. Increased water solubility.
  2. Improved absorption and distribution.
  3. Site specificity i.e. enhancing permeability.
  4. Stability (reducing metabolic liability using prodrugs)
  5. Prolonged release.
  6. Minimize toxicity. (Improving selectivity for intended target)
  7. Encourage patient acceptance.
  8. Elimination of formulation problems.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Bipartate prodrugs for increased water solubility.

A

Introduction of phosphates, amino acid esters or amide moieties into the molecule. (Enhance GIT solubility/absorption)

Enzymes such as phosphatases, esterases, amidases or peptidases in plasma or other tissues can then breakdown the molecules into its active form.

EX: Benzocaine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Bipartate carrier-linked prodrugs for improved absorption & distribution

A

If the desired drug is not absorbed and transported to the target site in sufficient concentration, it can be made more water-soluble or lipid soluble depending on the desired site of action.

Corticosteroids for the topical treatment of inflammatory, allergic and pruritic skin conditions can be made mroe suitable for topical absorption by esterification or acetonidation. Once absorbed through the skin, an esterase releases the drug.

EX: Triamcinolone Acetonide & Epinephrine (Dipivefrin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Bipartate carrier-linked prodrugs for site specificity i.e. enhancing permeability

A

Increasing the lipophilicity of the molecule by masking the polar functional groups and hydrogen bonds with ester or amide linkers is a common approach to address poor/passive permeability.

EX: acetylation of GABA with aliphatic or aromatic carboxylic acids.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

For stability (reducing metabolic liability) using bipartate carrier-linked prodrugs

A

Prodrugs can be used to protect against rapid metabolic breakdown and prolong the half-life of the drug by masking labile functions.

EX: Naltrexone. R= Anthranilyl or Acetylsalicyl.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

For Prolonged Release using bipartate carrier-linked prodrugs

A

Utility of prolonged release of drugs is several folds.

It reduces the number and frequency of doses required.

Eliminates night-time administration of drugs and the fact that the drug is taken less frequently, patient noncompliance is minimized.

EX: Tolmetin Sodium & Tolmetin prodrug by joining it with glycine amino acid.

Peak concentration duration: 1 hour, after prodrug: 9 hours.

17
Q

To encourage patient acceptance using bipartate carrier-linked prodrugs

A

An active drug may have an unpleasant taste or odor, produce gastric irritation, or cause pain when injected. The structure of the drug could be modified to alleviate these problems, but once administered, the prodrug would be metabolized to the active drug.

EX: Sulfisoxazole (R=H), Prodrug Sulfisoxazole Acetyl (R= COCH3)

18
Q

Elimination of Formulation problems using bipartate carrier-linked prodrugs

A

Formaldehyde is a flammable colorless gas with a pungent odor that is used as a disinfectant. Solutions of high concentrations of formaldehyde are toxic.

Hexamethylenetetramine (methenamine) can be used as a prodrug for formaldehyde. It releases HCHO in acidic conditions, urine in bladder can be made acidic.

Used as urinary tract antiseptic.

The reaction of formaldehyde with ammonia produces a stable adamantine like solid compound, methenamine (Hexamethylenetetramine)

19
Q

Tripartate carrier-linked prodrugs

A

Carrier-linker-drug ==Enzyme==> Carrier + Linker-Drug

Linker-Drug (spontaneouse separation) ===> Linker + Drug

Example: Bacampicillin (a prodrug for ampicillin)

20
Q

Mutual prodrugs

A

Two pharmacologically active agents are coupled together so that each acts as a promoiety for the other agent and vice versa.

A mutual prodrug is a bipartite or tripartate prodrug in which the carrier is a synergistic drug with the drug to which it is linked.

EX: Benorylate (Aspirin + Paracetamol), Sultamicillin ‘self-protection’ and Estramustine.